Evidence map›Paper›PMID 24162924›Full record

ArticleNature methods2013

Mapping differential interactomes by affinity purification coupled with data-independent mass spectrometry acquisition.

Jean-Philippe Lambert, Gordana Ivosev, Amber L Couzens, Brett Larsen, Mikko Taipale, Zhen-Yuan Lin, Quan Zhong, Susan Lindquist, Marc Vidal, Ruedi Aebersold and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature methods, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed
32.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 322 citations in OpenAlex.

  1. Relaxin-2: Shaping the Proteomic Landscape of Skeletal Muscle Physiology, Glucose Trafficking, and Mitochondrial Function in Rat.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The bronchoalveolar proteome changes in obesity.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Novel Phenotypical and Biochemical Findings in Mucolipidosis Type II.International journal of molecular sciences · 2025
    Article
  19. Article
  20. Review

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

Jean-Philippe Lambert1] Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. [2].
Gordana Ivosev
Amber L Couzens
Brett Larsen
Mikko Taipale
Zhen-Yuan Lin
Quan Zhong
Susan Lindquist
Marc Vidal
Ruedi Aebersold
Tony Pawson
Ron Bonner
Stephen Tate
Anne-Claude Gingras
Mount Sinai Hospital · CASciex (Canada) · CALunenfeld-Tanenbaum Research Institute · CAWhitehead Institute for Biomedical Research · USDana-Farber Cancer Institute · USHarvard University · USUniversity of Toronto · CAUniversity of Zurich · CH

Funding

Genomic Analysis of Network Perturbations in Human DiseaseP50HG004233 · NHGRI · DANA-FARBER CANCER INST · PI VIDAL, MARC · 2007 to 2017
$31.6M
The C. elegans Interactome ProjectR01HG001715 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI HILL, DAVID E., ROTH, FREDERICK P · 1998 to 2010
$16.5M
COMPUTATIONAL TOOLS FOR MASS SPECTROMETRY-BASED INTERACTOME DATAR01GM094231 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 2010 to 2026
$5.4M
Application of Technologies for Interactome Network Analyses of Cancer MutationsR33CA132073 · NCI · DANA-FARBER CANCER INST · PI VIDAL, MARC · 2008 to 2010
$1.8M
European Research Council 233226NCI NIH HHS R33 CA132073NHGRI NIH HHS P50 HG004233NHGRI NIH HHS R01 HG001715NIGMS NIH HHS R01 GM094231
6 · The paper itself

Abstract

Characterizing changes in protein-protein interactions associated with sequence variants (e.g., disease-associated mutations or splice forms) or following exposure to drugs, growth factors or hormones is critical to understanding how protein complexes are built, localized and regulated. Affinity purification (AP) coupled with mass spectrometry permits the analysis of protein interactions under near-physiological conditions, yet monitoring interaction changes requires the development of a robust and sensitive quantitative approach, especially for large-scale studies in which cost and time are major considerations. We have coupled AP to data-independent mass spectrometric acquisition (sequential window acquisition of all theoretical spectra, SWATH) and implemented an automated data extraction and statistical analysis pipeline to score modulated interactions. We used AP-SWATH to characterize changes in protein-protein interactions imparted by the HSP90 inhibitor NVP-AUY922 or melanoma-associated mutations in the human kinase CDK4. We show that AP-SWATH is a robust label-free approach to characterize such changes and propose a scalable pipeline for systems biology studies.

Indexed as

AutomationChromatography, AffinityChromatography, LiquidCyclin-Dependent Kinase 4Gene LibraryHumansIsoxazolesMass SpectrometryMutationPrincipal Component AnalysisProtein Interaction MappingProteinsResorcinolsSystems Biology5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamideCDK4 protein, humanCyclin-Dependent Kinase 4IsoxazolesProteinsResorcinols

Identifiers

PMID24162924
PMCPMC3882083
OpenAlexW1964328150

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.